by alice | Aug 21, 2026 | Clinicians, Media, Participants
We are pleased to share an update on the future of the ASPREE Study. With new funding from the National Cancer Institute in the United States, ASPREE is preparing to begin its third phase, called ASPREE-LT (Long-Term). This support allows us to continue following our...
by editor | Jun 20, 2021 | Researchers
New genomic tool advances melanoma risk prediction in older Australians Researchers have developed a new genomic risk score for melanoma (skin cancer), and shown it to be of value when used to predict melanoma risk in older people. Their findings were published...
by editor | Jan 3, 2017 | Clinicians, Participants, Researchers
Earlier this month we welcomed our U.S. research collaborators from the Berman Center for Outcomes and Clinical Research, along with guests from the National Cancer Institute (NCI), to discuss the progress and future of the ASPREE trial and sub-studies. The Berman...
by editor | Nov 30, 2015 | Clinicians, Participants, Researchers
Late last month saw the launch of an aspirin study called ADD-Aspirin to investigate whether aspirin can be used to prevent or delay the recurrence of a cancer. People living in India, Ireland and the UK who have had, or are undergoing early treatment for cancer in...
by editor | Oct 6, 2015 | Clinicians, Participants, Researchers
Researchers await verification of aspirin and cancer survival announcement A report that aspirin doubled the life expectancy of patients with gastrointestinal cancer should be viewed with caution until there is proof to substantiate the claim, said Australian...
Recent Comments